Resmed, a leader in sleep technology, has unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters.

Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

Shares of ResMed Inc. RMD slipped 2.47% to $220.22 Wednesday, on what proved to be an all-around mixed trading session for ...

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the Medical-Products industry group. Boston Scientific, Penum ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Resmed, a leader in health technology focused on sleep and respiratory care, has announced a significant brand evolution aimed at unifying its portfolio and enhancing direct consumer engagement.

StockNews.com cut shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research note published on Friday morning. Several other equities analysts have also issued reports ...

Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the ...